Molly Fletcher and LPGA veteran Michelle McGann
PONTE VEDRA BEACH, Fla.— The PGA TOUR and Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today a 3-year agreement in which Astellas will champion the PGA TOUR’s commitment to its new Women’s Initiative.
“The Women’s Initiative is an innovative platform designed to enhance the tournament experience for women and engage women in a meaningful and productive way in our tournament markets,” said PGA TOUR Commissioner Tim Finchem. “As a leading pharmaceutical company strongly committed to enhancing health, particularly in the area of urological wellness, Astellas is an ideal partner to help drive our Women’s Initiative and connect with women in settings they are already seeking out. We are delighted to collaborate with Astellas on this important and exciting venture.”
The Women’s Initiative is designed to provide women with information that promotes their overall well-being. Astellas and the PGA TOUR are working together to inform women about important health and wellness issues, encourage discussion on those topics and create opportunities to talk and learn about them.
Molly Fletcher will serve as the keynote speaker at multiple tournament locations, beginning with The Honda Classic Tournament on February 26 in Palm Beach Gardens, Fla. The initiative will span 17 tournaments during the 2013 TOUR Season.
Official press release: http://www.pgatour.com/company/2013/02/19/women.html
